SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-164649
Filing Date
2020-06-09
Accepted
2020-06-09 16:08:04
Documents
18
Period of Report
2020-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d941650d8k.htm   iXBRL 8-K 35656
2 EX-1.1 d941650dex11.htm EX-1.1 250303
3 EX-5.1 d941650dex51.htm EX-5.1 8059
4 EX-99.1 d941650dex991.htm EX-99.1 7991
5 EX-99.2 d941650dex992.htm EX-99.2 8250
9 GRAPHIC g941650g0609114155361.jpg GRAPHIC 2529
10 GRAPHIC g941650snap0001.jpg GRAPHIC 3829
  Complete submission text file 0001193125-20-164649.txt   520737

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20200608.xsd EX-101.SCH 3072
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20200608_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20200608_pre.xml EX-101.PRE 11409
15 EXTRACTED XBRL INSTANCE DOCUMENT d941650d8k_htm.xml XML 3357
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 20951914
SIC: 2834 Pharmaceutical Preparations